TABLE 5

Emax on cAMP and on MAPK of compounds tested on β2AR

Experimental data from Fig. 3B and 4A, presented as maximal response ± S.E.M. Data are expressed as percentage of the isoproterenol-stimulated response unless otherwise specified.



Emax
Ligand
cAMP
MAPK
Isoproterenol 100 100
Labetalol 31.5 ± 1.7 64.1 ± 7.3
Bucindolol −2.8 ± 1.8a 64.8 ± 8.3
Carvedilol −6.7 ± 7.0a 38.12 ± 6.4
Propranolol −43.9 ± 7.6a 40.6 ± 4.5
Metoprolol −59.2 ± 9.0a −41.2 ± 11.5b
Bisoprolol −59.4 ± 12.0a −51.6 ± 7.7b
Atenolol
−59.5 ± 10.8a
−55.8 ± 9.8b
  • a Forskolin response inhibition.

  • b PMA response inhibition.